CLINICAL_TRIALS
other
· 2011-06-17
Clinical Trial Update: China Made Sirolimus Eluting Stent for Intermediate Lesion [Phase 2, Phase 3]
Summary
A clinical trial update for a China-made sirolimus-eluting stent intended for intermediate coronary lesions, currently in Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: UNKNOWN